Jim Simons Vir Biotechnology, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,167,100 shares of VIR stock, worth $6.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,167,100

Previous 1,064,500 9.64%

Holding current value

$6.57 Million

Previous $5.37 Million 24.21%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$4.28 - $5.93 $439,128 - $608,418	102,600 Added 9.64%	1,167,100 $6.66 Million
Q2 2025 Aug 13, 2025	SELL	$4.5 - $6.48 $251,550 - $362,232	-55,900 Reduced 4.99%	1,064,500 $5.37 Million
Q1 2025 May 14, 2025	SELL	$6.48 - $12.48 $759,456 - $1.46 Million	-117,200 Reduced 9.47%	1,120,400 $7.26 Million
Q4 2024 Feb 13, 2025	BUY	$6.74 - $10.17 $372,722 - $562,401	55,300 Added 4.68%	1,237,600 $9.08 Million
Q3 2024 Nov 13, 2024	SELL	$7.26 - $10.7 $1.07 Million - $1.58 Million	-147,400 Reduced 11.09%	1,182,300 $8.86 Million

Q2 2024 Aug 09, 2024	SELL	$7.63 - $12.66 $201,432 - $334,224	-26,400 Reduced 1.95%	1,329,700 $11.8 Million
Q1 2024 May 13, 2024	BUY	$8.6 - $11.9 $528,900 - $731,850	61,500 Added 4.75%	1,356,100 $13.7 Million
Q4 2023 Feb 13, 2024	SELL	$7.76 - $10.29 $464,048 - $615,342	-59,800 Reduced 4.42%	1,294,600 $13 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $1.7 Million - $4.59 Million	186,300 Added 15.95%	1,354,400 $12.7 Million
Q2 2023 Aug 11, 2023	BUY	$23.2 - $27.29 $176,320 - $207,404	7,600 Added 0.65%	1,168,100 $28.7 Million
Q1 2023 May 12, 2023	BUY	$22.26 - $30.85 $2.27 Million - $3.15 Million	102,100 Added 9.65%	1,160,500 $27 Million
Q4 2022 Feb 13, 2023	SELL	$19.96 - $28.22 $9.06 Million - $12.8 Million	-454,094 Reduced 30.02%	1,058,400 $26.8 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $17.3 Million - $29.5 Million	950,094 Added 168.94%	1,512,494 $29.2 Million
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $8.93 Million - $12.5 Million	468,000 Added 495.76%	562,400 $14.3 Million
Q1 2022 May 13, 2022	BUY	$21.19 - $40.01 $773,435 - $1.46 Million	36,500 Added 63.04%	94,400 $2.43 Million
Q4 2021 Feb 11, 2022	BUY	$30.97 - $54.03 $1.79 Million - $3.13 Million	57,900 New	57,900 $2.42 Million
Q3 2021 Nov 12, 2021	SELL	$34.9 - $54.54 $2.8 Million - $4.37 Million	-80,102 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$38.75 - $51.0 $3.1 Million - $4.09 Million	80,102 New	80,102 $3.79 Million
Q2 2020 Aug 13, 2020	SELL	$27.89 - $47.86 $1.63 Million - $2.8 Million	-58,500 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$12.04 - $60.2 $704,340 - $3.52 Million	58,500 New	58,500 $2.01 Million

Others Institutions Holding VIR

# of Institutions

243

Shares Held

106M

Call Options Held

246K

Put Options Held

126K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $747M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account